Christoph A. Gebeshuber

Author

Medical University of Vienna ORCID

Also Known As

C A Gebeshuber, Christoph A Gebeshuber, Christoph A. Gebeshuber, Christoph Andreas Gebeshuber, Christoph Gebeshuber

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Medical University of Vienna Institute of Molecular Biotechnology Semmelweis University Christian Doppler Laboratory for Thermoelectricity Max Perutz Labs

About

Christoph A. Gebeshuber is an author at Medical University of Vienna specializing in medicine, cell biology, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	917
2	Cell Biology	7	7	906
3	Immunology	3	3	112
4	Natural Sciences	1	1	18
5	Cellular Physiology	1	1	83

Christoph A. Gebeshuber

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
miR‐29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis Christoph A. Gebeshuber, Kurt Zatloukal, Javier Martı̂nez EMBO Reports Mir‐29a Suppresses TristetraprolinCancer ResearchMedicineCancer Cell BiologyPathology	2009	387
The impact of target site accessibility on the design of effective siRNAs Hakim Tafer, Stefan L. Ameres, Gregor Obernosterer, Nature Biotechnology Effective SirnasComputer AccessibilityDesignUser ExperienceTarget Site Accessibility	2008	296
Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1 Christoph A. Gebeshuber, Christoph Kornauth, Lihua Dong, Nature Medicine GlomerulonephritisFocal Segmental GlomerulosclerosisMedicineRenal PathologyPathology	2013	227
miR-100 suppresses IGF2 and inhibits breast tumorigenesis by interfering with proliferation and survival signaling Christoph A. Gebeshuber Oncogene Breast OncologySurvival SignalingBreast CancerMir-100 Suppresses Igf2Microrna Detection	2012	92
MicroRNA-193a Regulates the Transdifferentiation of Human Parietal Epithelial Cells toward a Podocyte Phenotype Leonie Kietzmann, Sebastian S.O. Guhr, Tobias Meyer, Journal of the American Society of Nephrology Developmental BiologyPodocyte PhenotypeImmunologyMouse ModelExtracellular Microvesicles	2014	83
Annexin A1 attenuates EMT and metastatic potential in breast cancer Sabine Maschler, Christoph A. Gebeshuber, Memetcan Alacakaptan, EMBO Molecular Medicine Breast OncologyCancer BiologyMammary Gland DevelopmentTumor BiologyAnnexin A1	2010	82
ECM Characterization Reveals a Massive Activation of Acute Phase Response during FSGS Éva Nóra Bukosza, Christoph Kornauth, Karin Anna Hummel, International Journal of Molecular Sciences ImmunologyMolecular BiologyPathologyExtracellular MicrovesiclesInflammation	2020	18
Podocyte RNA sequencing reveals Wnt- and ECM-associated genes as central in FSGS Éva Nóra Bukosza, Klaus Kratochwill, Christoph Kornauth, PLoS ONE GeneticsTranscriptomics TechnologyGene CharacterizationNephrologyGenomics	2020	17
A systems pharmacology workflow with experimental validation to assess the potential of anakinra for treatment of focal and segmental glomerulosclerosis Michael Böehm, Éva Nóra Bukosza, Nicole Huttary, PLoS ONE Glomerular DiseaseExperimental ValidationRenal PathologyImmunologyPharmacotherapy	2019	11

Page 1